Related Experiment Video
Updated: Mar 28, 2026

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
Published on: April 19, 2020
Effect of Age on The Hepatocellularity Number for Wistar rats
Sarinj Fattah1, Patrick Augustijns1, Pieter Annaert2
1Drug Delivery and Disposition, KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
Insights
Hepatocellularity (HPGL) in juvenile rats is significantly higher than in adults, decreasing rapidly after weaning. This age-dependent profile is crucial for predicting drug clearance in pediatric safety studies.
Area of Science:
- Pharmacology
- Toxicology
- Animal Physiology
Background:
- Juvenile animal toxicity studies are increasingly vital for pediatric drug safety.
- Accurate study design necessitates understanding age-dependent pharmacokinetics.
- Physiologically based pharmacokinetic (PBPK) modeling aids in predicting drug exposure in young animals.
Purpose of the Study:
- To profile the age-dependent changes in hepatocellularity (number of hepatocytes per gram liver, HPGL) in male Wistar rats.
- To provide essential scaling factors for in vitro-in vivo extrapolation (IVIVE) in juvenile toxicity studies.
- To inform the design of pediatric drug safety evaluations.
Main Methods:
- Utilized the NADPH-cytochrome P450 reductase (NCR) activity method to determine HPGL.
- Compared NCR activity in liver homogenates versus suspended hepatocytes.
- Quantified HPGL in male Wistar rats across different age groups.
Main Results:
- Adult male Wistar rats (8 weeks) exhibited a mean HPGL of 104 × 10^6 cells/gram liver.
- HPGL values were significantly higher (p <0.001) in rat pups up to 3 weeks of age compared to adults.
- HPGL rapidly decreased after 3 weeks, reaching adult levels by 4 weeks of age.
Conclusions:
- The study established a clear age-dependent profile for HPGL in Wistar rats.
- This profile is critical for accurate hepatic drug clearance prediction in juvenile toxicity studies.
- The findings will enhance the design and reliability of pediatric drug safety assessments.
Abstract:
Recently there has been a substantial increase in the number of juvenile animal toxicity studies that are conducted to support pediatric drug safety evaluation. Adequate design of juvenile toxicity studies in rats, for instance with respect to dose levels per age group, requires an understanding of age-dependent pharmacokinetics. In vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modeling can help to anticipate age-dependent drug exposure in juvenile toxicity studies provided age-dependent profiles for animal physiology and scaling factors are available. For instance, when hepatocytes are used to predict hepatic drug clearance, the hepatocellularity (number of hepatocytes per gram liver, HPGL) is required as one of the scaling factors. Although HPGL is known for adult rats, information on the influence of age on HPGL is missing. The present work profiles the hepatocellularity number in male Wistar rats as a function of age. Using the NADPH-cytochrome P450 reductase (NCR) activity method, the mean HPGL for the adult rat (8 weeks) was 104 × 10(6) cells/gram liver (relative standard deviation 17%). This value was calculated as a ratio between NRC activities in liver homogenates and suspended hepatocytes. The HPGL values were significantly higher (p <0.001) for rat pups until 3 weeks of age compared with adults. Our results revealed that the HPGL value showed a rapid decrease after 3 weeks (end of weaning), essentially reaching adult values by 4 weeks. This age-dependent HPGL profile will be instrumental for hepatic drug clearance prediction when designing juvenile toxicity studies in Wistar rats.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

